Home > Share Market > Stocks > Bal pharma > Financial Statements > BALPHARMA Key Financial Ratios

Bal pharma Financial Statements

Bal pharma Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 46.40 (18) (8.60) 15.40
Op profit growth 414 (72) 16.30 (0.30)
EBIT growth (1,593) (109) 6.98 24.50
Net profit growth (139) (539) 58.30 25
Profitability ratios (%)        
OPM 9.76 2.78 8.23 6.47
EBIT margin 6.42 (0.60) 5.81 4.96
Net profit margin 1.89 (7.10) 1.33 0.77
RoCE 9.41 (0.60) 7.12 7.22
RoNW 2.24 (5.20) 1.09 0.75
RoA 0.69 (1.70) 0.41 0.28
Per share ratios ()        
EPS 3.18 (9.10) 0.27 --
Dividend per share 1 -- 1 1
Cash EPS (3.20) (14) (2.80) (3.30)
Book value per share 36.10 37 45.90 44.10
Valuation ratios        
P/E 16.90 (3.60) 286 --
P/CEPS (17) (2.30) (27) (26)
P/B 1.49 0.88 1.68 2.01
EV/EBIDTA 7.26 24.50 11.30 12
Payout (%)        
Dividend payout -- -- 50.90 80.60
Tax payout 14.90 (4.70) (87) (114)
Liquidity ratios        
Debtor days 85.10 121 110 94.70
Inventory days 93.30 143 106 76.90
Creditor days (84) (119) (108) (88)
Leverage ratios        
Interest coverage (1.30) 0.09 (1.30) (1.30)
Net debt / equity 1.98 2.20 1.62 1.42
Net debt / op. profit 4.34 24.20 6.12 5.97
Cost breakup ()        
Material costs (60) (49) (47) (51)
Employee costs (17) (29) (23) (20)
Other costs (13) (19) (22) (23)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000